A project led by Cornell’s Center for Point of Care Technologies for Nutrition, Infection and Cancer to develop a low-cost, battery-powered device for sample preparation in tuberculosis (TB) testing in areas with limited lab access and infrastructure, has received a $250,000 grant from the Gates Foundation.
For research excellence into how living structures recover and preserve order in morphology amid constant disruption, postdoctoral scientist Lanxi Hu has been awarded the Weill Institute for Cell and Molecular Biology’s 2025 Sam and Nancy Fleming Research Fellowship.
REEgen, a Cornell spinout focused on rare earth element (REE) recovery, won the $150,000 grand prize at the 2025 FuzeHub Commercialization Competition, held at the New York State Innovation Summit on Oct. 29-30.
Chemotherapy activates a stress sensor in immune cells, which may help explain why many cancer patients experience debilitating pain as a side effect, according to Weill Cornell Medicine and Wake Forest University researchers.
New study suggests that teens who understand the changes caused by puberty will be more confident in handling those changes, a concept called pubertal self-efficacy.
